31
LIFESCIENCELEADER.COM NOVEMBER 2014
With such a focus these days on buzzwords such as "patient-centric," "patient-cen-
tered," and "patient-centricity," some people are predicting "patient engagement" to be
the next big movement in our industry, much as blockbuster drugs were a decade or
more ago. But while improving patient engagement sounds fairly straightforward for
those who directly interact with patients (e.g., doctors, nurses, nurse practitioners, and
physicians assistants), for the biopharmaceutical industry, successfully executing this
concept has been — and continues to be — much more challenging.
HOW TO BUILD REAL
PATIENT-CENTERED
PHARMACEUTICAL
COMPANIES
R O B W R I G H T Chief Editor